Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam

Exclusion Criteria

• •1. Any disease or condition that might affect drug absorption, metabolism, or excretion, or clinically significant cardiovascular as determined by investigator
• •2. History of stomach or intestinal surgery, except for fully healed appendectomy and/or cholecystectomy which will be allowed
• •3. Clinically significant illness or clinically significant surgery within 4 weeks before the administration of study medication
• •4. Known or suspected hypersensitivity or allergic reaction to any of the components of CVC or DTG tablets, or midazolam syrup
• •5. Serum ALT, AST, or bilirubin values greater than or equal to Division of Acquired Immunodeficiency Syndrome (DAIDS) grade 1 at screening